Advanced Search


Study ID Status Title Patient Level Data
203820 Completed A two-part trial to evaluate the safety, tolerability, clinical effect and systemic exposure potential of topically applied GSK2981278 ointment in subjects with plaque psoriasis
203821 Completed Summary Document Analysis Plan for the Meta-Analysis and Assessment of Serious Event Outcomes in Patients with Persistent Asthma Receiving Salmeterol in Combination with Fluticasone as ADVAIR
204471 Completed A multi-centre, open label, single arm, 32-week treatment study in subjects with severe eosinophilic asthma not optimally controlled with current omalizumab treatment who are switched from omalizumab to mepolizumab 100mg subcutaneous (study number 204471- the OSMO study)
204476 Withdrawn Impact of a multiple micronutrient (MMN) beverage powder on vaccine response in school children (7-10yrs; inclusive) in Bangladesh: a randomised, double blind controlled trial
204477 Recruiting Clinical study to measure the impact of fortified malt based food on immunity outcomes in school children
204485 Active, Not Recruiting Epidemiological study Assessing the Burden of Illness Related to Severe Asthma in Quebec
204486 Active, not recruiting Cross-vaccination study of GSK Biologicals’ Lyophilized formulation of the Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A) in subjects who previously received placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) studies
204487 Not yet recruiting Immunogenicity and safety study of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A when co-administered with Prevenar13 in adults aged 50 years and older
204499 Not yet recruiting A Multicentre Observational Study with 90-days Follow-up Period to Evaluate Clinical Practice Variability as well as Clinical and Organisational Factors Related to Outcomes for COPD Hospital Admissions in Portugal
204500 Completed Salford Lung Studies: Follow-up Interviews on Patient-Centred Outcomes
204503 Terminated Assessment of cognitive function and mobility in individuals with pain
204509 Completed A single-centre, follow-up study to investigate the effect of GSK2245035 on nasal allergic reactivity in subjects who completed treatment in study TL7116958 in 2014 Study Listed on
204511 Recruiting An open label, multi-centre, post marketing surveillance (PMS) to monitor the safety and effectiveness of ANORO administered in Korean subjects with chronic obstructive pulmonary disease (COPD) in usual practice
204512 Not yet recruiting An Adaptive, Open-Label Study to Evaluate the Biodistribution of 89Zirconium-labelled GSK2398852 in the Heart and Other Organs of Patients with Transthyretin Cardiomyopathy (ATTR-CM) using Positron Emission Tomography (PET) Imaging
204516 Completed An Exploratory Study to Assess Two Accelerated Models of Barrier Repair
204521 Not yet recruiting Meta-analysis of Arnuity (FF) studies FFA109685 & FFA112059 Direct comparison of FF100 QD and FP 250 BD for Trough FEV1
204524 Active, not recruiting Nucala® Subcutaneous Injection Special Drug Use Investigation (Long-Term)
204645 Recruiting Seasonal Allergic Rhinitis Symptom Severity Observational Study
204646 Completed Bioequivalence Study of Dutasteride Capsules-An evaluation of the bioequivalence of dutasteride capsule manufactured at GSK compared to dutasteride capsule manufactured at Catalent in healthy Japanese male subjects Study Listed on
204653 Recruiting A phase I, open-label, dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK3326595 in subjects with solid tumors and non-Hodgkin’s lymphoma
204654 Recruiting Protocol to Characterize Severe Asthma Patient Experience of Treatment Benefit with an anti-IL5 with Clinical Trial Exit Interviews
204661 Completed PGx7612: Pharmacogenetic investigation of the association of the ADRB2 rare variant, Thr164Ile with severe asthma exacerbation
204663 Completed An exploratory study to assess the effect of topical application of Iodex® balm on local surface temperature using infra red thermal imaging technique
204664 Completed Meta-Analysis in sponsored studies MEA112997, MEA115588, and MEA115575 and a proof of concept investigator sponsored study CRT110184 of Mepolizumab in Severe Asthma
204673 Withdrawn A Phase I/II Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 Plus Trametinib in Subjects with Small Cell Lung Cancer and Ras-Mutated Solid Tumors



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.